Literature DB >> 27206493

Facile Approach To Construct Ternary Cocktail Nanoparticles for Cancer Combination Therapy.

Ping Huang1, Junping Ao2, Linzhu Zhou1, Yue Su1, Wei Huang1, Xinyuan Zhu1, Deyue Yan1.   

Abstract

Drug combinations have been widely used in cancer treatment. However, it remains a formidable challenge to deliver three or more therapeutic agents in one nanoparticle with a precise and tunable molar ratio because of differences in pharmacokinetics and biodistribution of various anticancer drugs. Herein, we reported a facile approach to construct ternary cocktail nanoparticles, which are composed of three different anticancer drugs, such as gemcitabine, chlorambucil, and irinotecan, through the molecular coassembly of two amphiphilic drug-drug conjugates. The component of these nanoparticles can be simply adjusted by changing the feed ratio of two amphiphilic drug-drug conjugates in the coassembly process. Without the help of any drug carriers, they can self-deliver, release three drugs synchronally, and obtain the optimal synergistic therapeutic effect. This facile strategy may open a new way for cancer combination therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27206493     DOI: 10.1021/acs.bioconjchem.6b00158

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  4 in total

1.  Drug-Triggered Self-Assembly of Linear Polymer into Nanoparticles for Simultaneous Delivery of Hydrophobic and Hydrophilic Drugs in Breast Cancer Cells.

Authors:  Sandeep Palvai; Libi Anandi; Sujit Sarkar; Meera Augustus; Sudip Roy; Mayurika Lahiri; Sudipta Basu
Journal:  ACS Omega       Date:  2017-12-07

Review 2.  Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models.

Authors:  Qilong Wang; Ping Zhang; Zhongmin Li; Xiangru Feng; Chengyue Lv; Huaiyu Zhang; Haihua Xiao; Jianxun Ding; Xuesi Chen
Journal:  Theranostics       Date:  2019-02-20       Impact factor: 11.556

3.  Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows in vitro and in vivo antitumor efficacy toward the treatment of nasopharyngeal cancer cells.

Authors:  Dongmei Liu; Wenguang Zhang; Xinju Liu; Rongliang Qiu
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

4.  Amphiphilic irinotecan-melampomagnolide B conjugate nanoparticles for cancer chemotherapy.

Authors:  Wenhao Qu; Quanjun Yang; Guanchun Wang; Zhaohong Wang; Ping Huang; Wei Huang; Rong Zhang; Deyue Yan
Journal:  RSC Adv       Date:  2020-03-02       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.